Albert Einstein College of Medicine has ranked #34 among 243 universities in the United States in the Cure Innovation Index, which evaluates institutions for their ability to translate scientific discoveries into real-world impact on healthcare. Einstein’s inclusion demonstrates its strength in consistently advancing innovations into therapies, companies, and measurable health outcomes.

The Cure Innovation Index is the first national, data-driven platform designed to assess how effectively U.S. biomedical research institutions convert discoveries into treatments, companies, and measurable health outcomes. The inaugural 2026 Index evaluates 303 leading institutions in all 50 states, the District of Columbia, and Puerto Rico, from more than 6,000 nationwide. It assesses institutions across 25 indicators within three core domains: research capabilities, entrepreneurial readiness, and market translation. Together, these dimensions capture the structural, cultural, and operational factors that enable institutions to move breakthroughs beyond the lab and into real-world applications.